Synthetic pig skin development factor (rEGF) is demonstrating increased interest as a promising strategy in the field of wound therapy. This biological molecule, manufactured through recombinant technology, offers a https://recombinant-porcine-egf741450.bloggingvalley.com/61606435/recombinant-swine-epidermal-growth-substance-a-effective-agent-for-tissue-repair